Use of Azithromycin in COVID-19: A Cautionary Tale
- PMID: 32816219
- PMCID: PMC7438973
- DOI: 10.1007/s40261-020-00961-z
Use of Azithromycin in COVID-19: A Cautionary Tale
Conflict of interest statement
Chia Siang Kow and Syed Shahzad Hasan declare no potential conflicts of interest.
Comment on
-
Azithromycin for COVID-19: More Than Just an Antimicrobial?Clin Drug Investig. 2020 Aug;40(8):683-686. doi: 10.1007/s40261-020-00933-3. Clin Drug Investig. 2020. PMID: 32533455 Free PMC article. No abstract available.
References
-
- Cetin ES, Gunes H, Kaya S, Aridogan BC, Demirci M. Distribution of genes encoding resistance to macrolides, lincosamides and streptogramins among clinical staphylococcal isolates in a Turkish university hospital. J Microbiol Immunol Infect. 2010;43(6):524–529. doi: 10.1016/S1684-1182(10)60081-3. - DOI - PubMed
-
- Malhotra-Kumar S, Lammens C, Coenen S, Van Herck K, Goossens H. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study. Lancet. 2007;369(9560):482–490. doi: 10.1016/S0140-6736(07)60235-9. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
